Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novartis AG Recalls Cough Syrups Due To Cap Seal Defect-Reuters


Thursday, 31 Jan 2013 04:44pm EST 

Reuters reported that Novartis AG said it is recalling 183 lots of cough syrup after discovering the child-resistant feature on some bottle caps was not functioning correctly. The Swiss drug company is recalling 142 lots of Triaminic and 41 lots of Theraflu Warming Relief Syrups manufactured in the United States before December 2011. The Company said it received four reports of accidental ingestion of the Triaminic syrup. One patient required medical attention but recovered. No adverse affects were reported with the Theraflu syrup, but the product is being recalled because it has the same cap as the malfunctioning Triaminic bottles. 

Company Quote

85.4
0.75 +0.89%
11:30am EDT